Why the study?
To explore the effects of the Hedysarum multijugum Maxim.-Radix Salviae compound (Huangqi-Danshen Compound) on oxidative capacity and cardiomyocyte apoptosis in rats with diabetic cardiomyopathy using a network pharmacology-based strategy.
Does Hedysarum multijugum Maxim.-Radix Salviae compound (HDC) improve oxidative capacity and cardiomyocyte apoptosis in rats with diabetic cardiomyopathy?
Population
Diabetic cardiomyopathy model rats
Comparison
Hedysarum multijugum Maxim.-Radix Salviae compound intervention
Design
Network pharmacology analysis and preclinical animal experiment
Authors
Loading...
Should not change practice; hypothesis-generating in rats and leaves open human translation for diabetic cardiomyopathy.
Does Hedysarum multijugum Maxim.-Radix Salviae compound (HDC) improve oxidative capacity and cardiomyocyte apoptosis in rats with diabetic cardiomyopathy?
HDC improves diabetic cardiomyopathy in a rat model by reducing oxidative stress and modulating cardiomyocyte apoptosis.
Zhang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: